Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regulatory T cells in autoimmune hepatitis: an updated overview
Maria Serena Longhi, Giorgina Mieli‐Vergani, Diego Vergani
Journal of Autoimmunity (2021) Vol. 119, pp. 102619-102619
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders – Advances and challenges
T. K. Goswami, Mithilesh Singh, Manish Dhawan, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 1
Open Access | Times Cited: 128
Autoimmmune hepatitis
Benedetta Terziroli Beretta‐Piccoli, Giorgina Mieli‐Vergani, Diego Vergani
Cellular and Molecular Immunology (2021) Vol. 19, Iss. 2, pp. 158-176
Open Access | Times Cited: 121
Diagnosis and management of autoimmune hepatitis
Luigi Muratori, Ansgar W. Lohse, Marco Lenzi
BMJ (2023), pp. e070201-e070201
Open Access | Times Cited: 117
Mesenchymal stem cell homing to improve therapeutic efficacy in liver disease
Mengqin Yuan, Xue Hu, Lichao Yao, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 53
Autoimmune hepatitis: Current and future therapies
Nancy Reau, Craig Lammert, Ethan M. Weinberg
Hepatology Communications (2024) Vol. 8, Iss. 6
Open Access | Times Cited: 8
Metabolism of hepatic stellate cells in chronic liver diseases: emerging molecular and therapeutic interventions
Mengyao Yan, Cui Yi-min, Qian Xiang
Theranostics (2025) Vol. 15, Iss. 5, pp. 1715-1740
Open Access | Times Cited: 1
The Regulatory-T-Cell Memory Phenotype: What We Know
Julia N. Khantakova, A.S. Bulygin, С. В. Сенников
Cells (2022) Vol. 11, Iss. 10, pp. 1687-1687
Open Access | Times Cited: 29
CD4+ T-cell subsets in autoimmune hepatitis: A review
Hao Chen, Zhongyu Han, Yiyue Fan, et al.
Hepatology Communications (2023) Vol. 7, Iss. 10
Open Access | Times Cited: 16
Remodeling of T-cell mitochondrial metabolism to treat autoimmune diseases
Liyan Lin, Ruyu Ren, Qiao Xiong, et al.
Autoimmunity Reviews (2024) Vol. 23, Iss. 6, pp. 103583-103583
Open Access | Times Cited: 6
Could a reduced hemoglobin, albumin, lymphocyte, and platelet (HALP) score predict autoimmune hepatitis and degree of liver fibrosis?
Müge Ustaoğlu, Gülali Aktaş, Ömer Küçükdemirci, et al.
Revista da Associação Médica Brasileira (2024) Vol. 70, Iss. 1
Open Access | Times Cited: 5
The significance of gut microbiota in the etiology of autoimmune hepatitis: a narrative review
Chen Sun, Dongzi Zhu, Qi Zhu, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 5
Pleiotropic Action of TGF-Beta in Physiological and Pathological Liver Conditions
Michał Braczkowski, Klaudia Maria Kufel, Julia Kulińska, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 925-925
Open Access | Times Cited: 5
Regulatory T Cells and Their Derived Cell Pharmaceuticals as Emerging Therapeutics Against Autoimmune Diseases
Yu Liu, Yiqiu Fu, Rourou Miao, et al.
Advanced Functional Materials (2024)
Closed Access | Times Cited: 5
Cellular interactions in self-directed immune mediated liver diseases
Amber G. Bozward, Scott Davies, Sean Michael Morris, et al.
Journal of Hepatology (2025)
Closed Access
Maternal and fetal outcomes of autoimmune hepatitis in pregnancy: A United States hospitalized patient study
Xi Li, Jing Zhang, Sheza Malik, et al.
Clinics and Research in Hepatology and Gastroenterology (2025) Vol. 49, Iss. 3, pp. 102544-102544
Closed Access
Role of regulatory T cells in inflammatory liver diseases
Linjie Yang, Song Guo Zheng
Autoimmunity Reviews (2025), pp. 103806-103806
Closed Access
Regulatory T cell-based therapies for type 1 diabetes: a narrative review
Tsvetelina Velikova, Georgi Vasilev, Diya Linkwinstar, et al.
Metabolism and Target Organ Damage (2025) Vol. 5, Iss. 2
Open Access
The dual role of TIGIT in regulatory and effector T cells in chronic liver disease
Amber G. Bozward, Scott Davies, Rémi Fiancette, et al.
JHEP Reports (2025), pp. 101405-101405
Open Access
Immunology of Autoimmune Liver Diseases
Kayani Kayani, Amber G. Bozward, Scott Davies, et al.
Elsevier eBooks (2025)
Closed Access
Immune cell phenotypes as causal factors in liver disease progression revealed by Mendelian randomization
Jingtao Huang, Wenlu Zou, Zhihua Lv, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Impact of Antigen Presentation Mechanisms on Immune Response in Autoimmune Hepatitis
Rossella Fasano, Eleonora Malerba, Marcella Prete, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 22
The role of amino acid metabolism in autoimmune hepatitis
Xiaorong Xiang, Qihong Li, Jiajia Wan, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116452-116452
Open Access | Times Cited: 4
Autoimmune hepatitis
Benedetta Terziroli Beretta‐Piccoli, Giorgina Mieli‐Vergani, D. Vergani
Elsevier eBooks (2024), pp. 869-904
Closed Access | Times Cited: 4
Endogenous ERMAP Affects T‐Cell Function in EAE Mice
Keke He, Kezhu Chen, Rong Hu, et al.
Immunology (2025)
Closed Access
Regulatory T cell therapy in autoimmune liver disease and transplantation
Marian V. Fleming, Alberto Sánchez‐Fueyo, Niloufar Safinia
JHEP Reports (2025), pp. 101394-101394
Open Access
Page 1 - Next Page

Scroll to top